Trials / Completed
CompletedNCT02918942
Tympanoseal (Tympanic Membrane Device) Clinical Study
- Status
- Completed
- Phase
- —
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Grace Medical, Inc. · Industry
- Sex
- All
- Age
- 2 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this investigational study is to assess the ability of Tympanoseal (sodium/calcium alginate), an investigational device, to act as a scaffold during healing of the tympanic membrane. Tympanoseal is intended for use following removal or extrusion of indwelling tympanostomy tubes or traumatic injury of the tympanic membrane.
Detailed description
This study will provide data on the safety and the ability of sodium/calcium alginate gels to act as a scaffold capable of occluding a tympanic membrane perforation over the duration of complete healing. Tympanoseal could be used in cases where cartilage or fat graft tympanoplasty would be indicated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tympanoseal | All subjects will receive the Tympanoseal device that will be placed during a surgical procedure. |
Timeline
- Start date
- 2016-10-04
- Primary completion
- 2021-09-30
- Completion
- 2021-09-30
- First posted
- 2016-09-29
- Last updated
- 2024-10-15
- Results posted
- 2024-10-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02918942. Inclusion in this directory is not an endorsement.